The new anti-interleukin-1beta monoclonal antibody, gevokizumab, reduces hs-crp in subjects with type 2 diabetes mellitus

被引：0
|
作者：
Feldstein, J. [1 ]
Davis, S. N. [2 ]
Zayed, H. [1 ]
Whitmore, J. [1 ]
机构：
[1] XOMA LLC, Berkeley, CA USA
[2] Univ Maryland, Baltimore, MD 21201 USA
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1015 / 1015
页数：1
相关论文
共 50 条
  • [1] Combination Studies of the Anti-Interleukin-1beta Monoclonal Antibody XOMA 052 with Exendin-4 or Sitagliptin in a Diet-Induced Obesity Mouse Model of Type 2 Diabetes Mellitus
    Lee, Steve
    Owyang, Alexander M.
    Gross, Lisa
    El Bader, Suzy
    Yin, Johnny
    Bhaskar, Vin
    Maedler, Kathrin
    Kantak, Seema
    DIABETES, 2010, 59 : A474 - A474
  • [2] ROLE OF HBA1C AND HS-CRP IN TYPE 2 DIABETES MELLITUS WITH CARDIOVASCULAR DISEASES
    Anand, Pallavi
    Arya, Manju Lata
    Kumar, Vikas
    Jain, Renu
    Jyotirmay
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (99): : 16407 - 16410
  • [3] The effect of benfotiamine on high Sensitivity-CRP (hs-CRP) level in patients with type 2 diabetes mellitus
    Kim, Dooman
    Kim, Hyunkyu
    Nam, Hong Woo
    DIABETES, 2007, 56 : A550 - A551
  • [4] Correlation of hs-CRP with glycemic control and microvascular complications in adults with type 2 diabetes mellitus
    Akbani, Adil A. Raheman
    Kuthe, Shilpa Sachin
    Humaney, Nalini Rajesh
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2025,
  • [5] The Effects of Rosiglitazone on the hs-CRP in Acute Coronary Syndrome Patients with Type 2 Diabetes Mellitus
    Sun Cuifang
    CIRCULATION, 2010, 122 (02) : E248 - E248
  • [6] Anti-Inflammatory Effect of Monthly Subcutaneous Gevokizumab in Subjects With Type 2 Diabetes Mellitus on Stable Metformin
    Feldstein, Jeffrey D.
    Davis, Stephen N.
    Whitmore, Jennifer
    Zayed, Hany
    DIABETES, 2013, 62 : A438 - A438
  • [7] Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus
    Elizondo-Montemayor, Leticia
    Gonzalez-Gil, Adrian M.
    Tamez-Rivera, Oscar
    Toledo-Salinas, Carla
    Peschard-Franco, Mariana
    Rodriguez-Gutierrez, Nora A.
    Silva-Platas, Christian
    Garcia-Rivas, Gerardo
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [8] Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    Herold, KC
    Hagopian, W
    Auger, JA
    Poumian-Ruiz, E
    Taylor, L
    Donaldson, D
    Gitelman, SE
    Harlan, DM
    Xu, DL
    Zivin, RA
    Bluestone, JA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22): : 1692 - 1698
  • [9] The clinical value of hs-CRP, omentin-1, and new inflammation indicators in gestational diabetes mellitus screening
    Zhu, Xiaocui
    Zhang, Yunling
    Cui, Shaoyong
    Cai, Ruiying
    Li, Sen
    Yao, Xinjie
    Zhang, Yan
    Zhang, Changgeng
    MINERVA MEDICA, 2023,
  • [10] A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
    McKie, Elizabeth A.
    Reid, Juliet L.
    Mistry, Prafull C.
    DeWall, Stephen L.
    Abberley, Lee
    Ambery, Philip D.
    Gil-Extremera, Blas
    PLOS ONE, 2016, 11 (03):
12345